Archives for September 25, 2017

Biotech Week Boston

Protein A's mAb capture efficacy offsets cost, says GE launching new offering

GE Healthcare has launched a Protein A resin it says can improve monoclonal antibody purification capacity by up to 40% compared to its current offering.

US FDA red light for Janssen’s arthritis mAb

The US FDA has rejected Janssen Biotech’s application for sirukumab, a monoclonal antibody (mAb) designed to treat severely active rheumatoid arthritis (RA). 

ADC Biotechnology secures $11m for commercial biomanufacturing plant

ADC Biotechnology has announced it will spend $11m ($9.2m) build a bio-conjugation facility at a site in Deeside, North Wales.